Dawson Knoblock

1.1k total citations
8 papers, 695 citations indexed

About

Dawson Knoblock is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Dawson Knoblock has authored 8 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Epidemiology and 2 papers in Hematology. Recurrent topics in Dawson Knoblock's work include Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Dawson Knoblock is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Dawson Knoblock collaborates with scholars based in United States, India and United Kingdom. Dawson Knoblock's co-authors include Cristina Del Bianco, Yumi Yashiro–Ohtani, Terry Fang, Warren S. Pear, Stephen C. Blacklow, Gregory L. Beatty, Patrick Guirnalda, Kristen B. Long, Cynthia Clendenin and Jae W. Lee and has published in prestigious journals such as Blood, Immunity and Gastroenterology.

In The Last Decade

Dawson Knoblock

8 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawson Knoblock United States	7	403	337	194	69	49	8	695
Samuel Alsén Sweden	9	513 1.3×	277 0.8×	191 1.0×	41 0.6×	43 0.9×	15	737
Eunseon Ahn United States	8	675 1.7×	466 1.4×	208 1.1×	43 0.6×	75 1.5×	14	960
Kito Nzingha United States	7	783 1.9×	557 1.7×	214 1.1×	66 1.0×	62 1.3×	8	1.0k
Angela Colmone United States	9	375 0.9×	191 0.6×	174 0.9×	58 0.8×	39 0.8×	33	757
Seiji Nagano Japan	12	232 0.6×	335 1.0×	277 1.4×	26 0.4×	32 0.7×	25	607
Yiyi Yan United States	13	454 1.1×	496 1.5×	248 1.3×	53 0.8×	31 0.6×	38	878
Carolina I. Domaica Argentina	19	1.0k 2.5×	424 1.3×	281 1.4×	60 0.9×	67 1.4×	25	1.2k
Renee Wu United States	9	726 1.8×	383 1.1×	194 1.0×	30 0.4×	43 0.9×	13	930
Irene Olivera Spain	12	360 0.9×	259 0.8×	139 0.7×	39 0.6×	25 0.5×	24	544
Tiziano Ingegnere Italy	11	391 1.0×	280 0.8×	161 0.8×	27 0.4×	21 0.4×	15	604

Countries citing papers authored by Dawson Knoblock

Since Specialization

Citations

This map shows the geographic impact of Dawson Knoblock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawson Knoblock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawson Knoblock more than expected).

Fields of papers citing papers by Dawson Knoblock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawson Knoblock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawson Knoblock. The network helps show where Dawson Knoblock may publish in the future.

Co-authorship network of co-authors of Dawson Knoblock

This figure shows the co-authorship network connecting the top 25 collaborators of Dawson Knoblock. A scholar is included among the top collaborators of Dawson Knoblock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawson Knoblock. Dawson Knoblock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Lowther, Daniel E., E. Andrés Houseman, Guangchun Han, et al.. (2023). P41 NO EVIDENCE OF B-CELL MATURATION ANTIGEN (BCMA) EXPRESSION LOSS OR SYSTEMIC IMMUNE IMPAIRMENT AFTER TREATMENT WITH THE BCMA-TARGETED ANTIBODY-DRUG CONJUGATE BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. HemaSphere. 7(S2). 33–34. 1 indexed citations

Lowther, Daniel E., E. Andrés Houseman, Gang Han, et al.. (2022). No Evidence of BCMA Expression Loss or Systemic Immune Impairment after Treatment with the BCMA-Targeted Antibody-Drug Conjugate (ADC) Belantamab Mafodotin (Belamaf) in the DREAMM-1 and DREAMM-2 Trials of Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 140(Supplement 1). 611–613. 8 indexed citations

Aggarwal, Charu, Roger B. Cohen, Matthew P. Morrow, et al.. (2020). Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis. Vaccines. 8(1). 56–56. 20 indexed citations

Jaeger, Ulrich, Michael Bishop, Gilles Salles, et al.. (2020). Myc Expression and Tumor-Infiltrating T Cells Are Associated with Response in Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) Treated with Tisagenlecleucel in the Juliet Trial. Blood. 136(Supplement 1). 48–49. 16 indexed citations

Morrow, Matthew P., Kimberly A. Kraynyak, Albert J. Sylvester, et al.. (2017). Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy. Clinical Cancer Research. 24(2). 276–294. 34 indexed citations

Bengsch, Fee, et al.. (2017). CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer. Cancer Immunology Immunotherapy. 66(12). 1609–1617. 84 indexed citations

Beatty, Gregory L., Rafael Winograd, Rebecca A. Evans, et al.. (2015). Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages. Gastroenterology. 149(1). 201–210. 228 indexed citations

Fang, Terry, Yumi Yashiro–Ohtani, Cristina Del Bianco, et al.. (2007). Notch Directly Regulates Gata3 Expression during T Helper 2 Cell Differentiation. Immunity. 27(1). 100–110. 304 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact